Tricyclic antidepressants (TCAs) modulate neurotransmitter systems by inhibiting the reuptake of serotonin and norepinephrine, potentially reducing neuronal hyperexcitability associated with Visual Snow Syndrome. By altering neural signaling and potentially dampening cortical hyperactivity, TCAs may help mitigate visual disturbances and associated neurological symptoms through their complex neuromodulatory effects.